Status:
COMPLETED
Melanil in the Treatment of Melasma
Lead Sponsor:
Catalysis SL
Conditions:
Melasma
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
The purpose of the study is to assess the efficacy of Melanil facial cream in the treatment of melasma. The duration of this double-blind phase 3 clinical trial will be 54 weeks. The control group wil...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Melasma
- Fitzpatrick's skin types I to IV
- Signed informed consent
- Given verbal agreement on protection from UV light during treatment by the usage of physical barriers (umbrellas, caps, hats, etc).
Exclusion
- Fitzpatrick's skin types V and VI
- Treatment with steroids within the duration of the clinical trial.
- Oral contraception within the duration of the clinical trial
- Usage of other cosmetics within the duration of the clinical trial
- Treatment with Clofazimine within the duration of the clinical trial
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2010
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01001624
Start Date
October 1 2009
End Date
November 1 2010
Last Update
May 4 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
"Cdte. Manuel Fajardo Rivero" Clinical-Surgical-Docent Hospital
Havana, La Habana, Cuba, 10400